{"id":"NCT02990806","sponsor":"Nichi-Iko Pharmaceutical Co., Ltd.","briefTitle":"A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE)","officialTitle":"A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-19","primaryCompletion":"2019-05-20","completion":"2019-05-20","firstPosted":"2016-12-13","resultsPosted":"2023-01-25","lastUpdate":"2023-01-30"},"enrollment":683,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"NI-071","otherNames":[]},{"type":"DRUG","name":"Remicade","otherNames":[]}],"arms":[{"label":"Stages 1, 2 and 3: NI-071 Group","type":"EXPERIMENTAL"},{"label":"Stage 1: Remicade-US Group","type":"EXPERIMENTAL"},{"label":"Stage 2 and Stage 3: Remicade US to Remicade-US Group","type":"EXPERIMENTAL"},{"label":"Stage 2 and Stage 3: Remicade US to Switch Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to demonstrate similarity of NI-071 (proposed biosimilar to infliximab) to US REMICADE® (reference product) in terms of safety and efficacy in participants with rheumatoid arthritis (RA) not adequately responding to methotrexate (MTX).","primaryOutcome":{"measure":"Stage 1: Percentage of Participants Who Achieved 20 Percent (%) American College of Rheumatology C-reactive Protein (ACR20-CRP) Response Rate at Week 22","timeFrame":"At Week 22","effectByArm":[{"arm":"Stage 1: NI-071 Group","deltaMin":56.6,"sd":null},{"arm":"Stage 1: Remicade-US Group","deltaMin":53,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":134,"countries":["United States","Czechia","Poland","Puerto Rico","Russia","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":227},"commonTop":["Nasopharyngitis","Upper Respiratory Tract Infection","Headache","Alanine Aminotransferase Increased","Bronchitis"]}}